Baseline characteristics of patients in the BOREAS-CAG Registry
| Overall (n=1150) | AF (n=111) | Non-AF (n=1039) | p Value | |
|---|---|---|---|---|
| Age (years) | 68.8±12.0 | 71.2±8.5 | 68.5±12.3 | 0.026 |
| Sex (male) | 772 (67.1) | 72 (64.9) | 700 (67.6) | 0.555 |
| BMI (kg/m2) | 24.4±4.0 | 24.5±4.3 | 24.4±4.0 | 0.795 |
| CAD | 574 (49.9) | 35 (31.5) | 539 (51.9) | <0.001 |
| Smoking | 648 (60.1) | 67 (61.5) | 581 (60.0) | 0.760 |
| Systolic BP (mm Hg) | 142.6±29.0 | 131.7±26.1 | 143.8±29.0 | <0.001 |
| HT | 751 (69.0) | 76 (68.5) | 675 (69.1) | 0.893 |
| DM | 408 (37.6) | 35 (31.5) | 373 (38.3) | 0.161 |
| DL | 582 (53.9) | 45 (40.5) | 537 (55.4) | 0.003 |
| UA (mg/dL) | 5.9±1.8 | 6.4±2.0 | 5.9±1.7 | 0.002 |
| eGFR (mL/min/1.73m2) | 65.5±30.0 | 55.7±21.7 | 66.6±30.6 | <0.001 |
| BNP (pg/mL) | 48.0 (18.6-131.5) | 148.0 (69.3-496.0) | 42.4 (17.0-105.0) | <0.001* |
| LDL (mg/dL) | 107.5±32.8 | 100.1±29.9 | 108.3±33.0 | 0.021 |
| HbA1c (%) | 6.3±1.3 | 6.3±1.1 | 6.3±1.3 | 0.872 |
| β blocker | 273 (25.8) | 50 (45.5) | 223 (23.6) | <0.001 |
| ACEI/ARB | 471 (44.4) | 54 (49.1) | 417 (43.9) | 0.295 |
| Statin | 472 (44.6) | 29 (26.6) | 443 (46.7) | <0.001 |
| Nicorandil | 246 (23.3) | 16 (14.8) | 230 (24.3) | 0.028 |
Data are given as the mean±SD or medians (IQRs), or number of patients with percentage in brackets.
*Kruskal-Wallis test.
ACEI/ARB, angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers; AF, atrial fibrillation; BNP, B-type natriuretic peptide; BMI, body mass index; CAD, coronary artery disease; DL, dyslipidemia; DM, diabetes mellitus; eGFR, estimated glomerular filtration ratio; HT, hypertension; LDL, low-density lipoprotein cholesterol; UA, uric acid.